Introduction {#Sec1}
============

The brain extracts information about the world that shapes our behavior and ultimately influences who we are as individuals. The immense capacity and specificity of memory storage in the mammalian central nervous system is thought to depend on the modifiability or plasticity of synaptic connections. Dysfunction of synaptic plasticity is implicated in a range of disorders from Alzheimer's disease to mental retardation and development of chronic pain states. Understanding how neural activity patterns are translated into lasting changes in synaptic connectivity is therefore one of the most important challenges in basic and clinical neuroscience (Bliss et al. [@CR9]; Citri and Malenka [@CR29]; Nelson and Turrigiano [@CR91]).

Glutamatergic synapses are capable of expressing diverse forms of plasticity in response to synaptic input, including several mechanistically distinct kinds of synaptic strengthening (potentiation), weakening (depression), and homeostatic synaptic scaling. Key to current thinking is the requirement for new gene expression and protein synthesis in the development of enduring synaptic modifications and long-term changes in behavior, probably involving orchestrated synthesis and degradation of hundreds of proteins (Lee et al. [@CR68]; Park et al. [@CR98]; Wibrand et al. [@CR146]; Havik et al. [@CR49]; Liao et al. [@CR71]).

The dendritic tree of a typical projection neuron in the adult mammalian brain contains some 10,000 dendritic spines onto each of which a single excitatory, glutamatergic synapse is formed. As a discrete structural, physiological, and biochemical compartment, dendritic spines offer a necessary degree of synaptic autonomy for information processing and storage. But, since gene expression occurs in the nucleus, how does activation of a small set of synapses lead to protein synthesis-dependent modification of those synapses? One attractive mechanism for this, as originally conceived by Oswald Steward and colleagues, is dendritic protein synthesis (Steward and Levy [@CR123]; Steward and Reeves [@CR124]; Steward and Schuman [@CR125]; Bramham and Wells [@CR16]). Through activity-dependent local synthesis and degradation of proteins, synaptic inputs may directly remodel the protein composition, and thereby the functional state, of individual dendritic spines or spine neighborhoods.

This review highlights the special functional relevance of the immediate early gene (IEG) Arc/Arg3.1 (activity-regulated cytoskeleton-associated protein/activity-regulated gene 3.1), for simplicity henceforth referred to as Arc. The discovery of Arc was independently reported by the laboratories of Dietmar Kuhl and Paul Worley in 1995 (Link et al. [@CR72]; Lyford et al. [@CR75]). Uniquely, *Arc* mRNA is induced by synaptic activity and trafficked rapidly to dendrites where the RNA accumulates at sites of synaptic activity and undergoes local translation (Link et al. [@CR72]; Lyford et al. [@CR75]; Steward et al. [@CR127]; Yin et al. [@CR149]; Moga et al. [@CR84]; Rodriguez et al. [@CR111]). The implications from the original discovery of Arc have now been borne out in studies establishing a function for the protein in multiple forms of protein synthesis-dependent synaptic plasticity, including LTP elicited by high-frequency afferent stimulation (HFS) or infusion of brain-derived neurotrophic factor (BDNF), and LTD mediated by activation of group 1 metabotropic glutamate receptors (mGluRs). Various aspects of Arc have been discussed in focused reviews and commentaries (Tzingounis and Nicoll [@CR135]; Castillo et al. [@CR23]; Kubik et al. [@CR64]; Bramham et al. [@CR17]). Here, we attempt to overview the Arc system spanning from regulation of *Arc* RNA and protein, to functions in synaptic plasticity and adaptive behavior such as memory storage, and maladaptive behavior such as drug addiction.

Transcriptional regulation of Arc {#Sec2}
=================================

*Arc* mRNA is rapidly expressed in principal neurons of rodent forebrain following seizures, learning experience, and following induction of LTP by HFS or BDNF (Link et al. [@CR72]; Lyford et al. [@CR75]; Steward et al. [@CR127]; Waltereit et al. [@CR141]; Ying et al. [@CR150]; Kubik et al. [@CR64]). However, the signal-transduction cascades that connect synaptic activity to transcription in the nucleus are not fully understood. Activation of *N*-methyl-[d]{.smallcaps} aspartate receptor (NMDAR) type glutamate receptors and extracellular signal-regulated kinase (ERK) are necessary for *Arc* transcription following LTP induction (Steward et al. [@CR127]; Steward and Worley [@CR126]; Panja et al. [@CR97]) and in response to neuronal activity in primary hippocampal or cortical neuronal cultures (Rao et al. [@CR108]). *Arc* is also induced pharmacologically in hippocampal neurons by BDNF, application of the group 1 mGluR agonist dihydroxyphenylglycine (DHPG), or activation of adenylate cyclase by forskolin (Waltereit et al. [@CR141]; Alder et al. [@CR1]; Rao et al. [@CR108]; Yasuda et al. [@CR148]; Wang et al. [@CR144]). Elevation of intracellular calcium and cAMP levels induces *Arc* in pheochromocytoma 12 cells and hippocampal neurons in a manner dependent on protein kinase A (PKA) and ERK activation (Waltereit et al. [@CR141]). In SH-SY5Y neuroblastoma cells, muscarinic acetylcholine receptor agonists enhance *Arc* expression via the cytoplasmic tyrosine kinase Src and protein kinase C (PKC), both of which are upstream of ERK (Teber et al. [@CR131]). Interestingly, AMPA-type glutamate receptors downregulate *Arc* gene expression in hippocampal neurons and organotypic hippocampal slice cultures through a pertussis toxin-sensitive G protein (Rao et al. [@CR108]), suggesting that active neuronal networks are subject to negative feedback at the level of *Arc* transcription. While ERK appears to have a coordinating function, further work on the cross-talk between ERK, PKA, and PKC signaling is likely to be important for understanding the context-specific regulation of *Arc* transcription (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1*Arc* transcriptional regulation, transport, and docking. *Arc* expression is induced by signaling cascades that regulate transcription factors in response to synaptic activity. The diagram depicts the genomic organization of the synaptic activity-responsive element (*SARE*) and other regulatory elements upstream of the *Arc* open reading frame that serve as binding sites for these transcription factors. Following transcription, *cis*-regulatory elements of the *Arc* mRNA regulate its assembly into transport mRNPs. The dendritic localization and stability of the mRNA in dendrites is a result of active microtubule-based transport and local F-actin-dependent docking. Upon translation,*Arc* RNA is subject to rapid nonsense-mediated RNA decay. *A2RE* hnRNP A2 response element; *BDNF* brain-derived neurotrophic factor; *CREB* CRE-binding protein; *CRE* cAMP response element; *DTE* dendritic targeting elements; *UTR* untranslated region; *ERK* extracellular signal-regulated kinase; *IRES* internal ribosome entry site; *mACh-R* muscarinic acetylcholine receptor; *MEF2* myocyte enhancing factor; *NMDA-R* NMDA-receptor; *ORF* open reading frame; *PKA* cAMP-dependent protein kinase; *PKC* protein kinase C; *SRE* serum response element; *SRF* serum response factor

Recent work has identified response elements in the *Arc* promoter underlying its activity-dependent transcriptional regulation. Waltereit et al. ([@CR141]) originally identified two serum response elements (SRE) at approximately \~0.9 kb and \~1.5 kb upstream of the transcription initiation site, but these elements were dispensable for transcriptional activation by calcium and cyclic AMP. Using a DNase I hypersensitivity assay to screen endogenous chromatin for important transcriptional regulatory regions, Pintchovski et al. ([@CR103]) identified two new enhancer elements located \~6.5 kb and \~1.4 kb upstream of the *Arc* transcription startsite. The distal enhancer has a highly conserved SRE that binds serum response factor (SRF) and is recruited by synaptic activity, forskolin and BDNF. The proximal site contains a conserved "Zeste-like" element that enhances *Arc* induction by synaptic activity and BDNF application (Pintchovski et al. [@CR103]). Interestingly, the *Arc* promoter also holds a unique activity-sensor named the synaptic activity-responsive element (SARE) which is \~100 bp in size and located at \~7 kb upstream of the *Arc* transcription initiation site (Kawashima et al. [@CR58]). Consisting of a unique cluster of binding sites for CREB, SRF, and myocyte enhancer factor-2 (MEF2) protein, the SARE is necessary for *Arc* transcription and sufficient to confer rapid, synaptic activity-induced *Arc* expression in hippocampal neurons. The SARE is also responsive to experience in live animals, as demonstrated by enhanced expression of a GFP-tagged SARE reporter in neurons of the primary visual cortex in mice that were exposed to light following a period of dark-rearing. Altogether, a set of elements have been identified within the 7-kb region of the *Arc* promoter which collectively recapitulate most of the known features of *Arc* transcription (Fig. [1](#Fig1){ref-type="fig"}).

Arc RNA transport and regulation of RNA docking {#Sec3}
===============================================

*Arc* mRNA is a member of the growing family of dendritically targeted mRNAs. Within 1 h of transcription, *Arc* mRNA is detected in the distal dendrites of dentate granule cells up to 300 μm away from the cell bodies (Link et al. [@CR72]; Lyford et al. [@CR75]; Steward et al. [@CR127]; Wallace et al. [@CR140]). *Arc* mRNA is also detected in preparations of brain synaptoneurosomes and in dendrites of neurons in culture (Bagni et al. [@CR3]; Yin et al. [@CR149]; Havik et al. [@CR48]; Kanai et al. [@CR56]; Giorgi et al. [@CR44]) indicating that *Arc* mRNA is present at low levels in dendrites under non-stimulating conditions. Evidence also suggests that translation of pre-existing *Arc* mRNA stores in dendrites underlies DHPG-induced LTD (Waung et al. [@CR145]).

RNAs destined for dendrites are born naked and packaged into messenger ribonucleoprotein (mRNP) particles (also know as transport RNPs) that contain cognate RNA-binding proteins, components of the translational machinery, and molecular motors involved in RNA transport, localization and decay. mRNP assembly is a complex and incompletely understood process that starts in the nucleus and continues in the cytoplasm (Fig. [1](#Fig1){ref-type="fig"}). The *Arc* 3′UTR contains two *cis*-acting dendritic targeting elements (DTE) required for dendritic localization of a nuclear transcribed reporter mRNA in hippocampal neurons (Kobayashi et al. [@CR61]). Surprisingly, removal of the 3′UTR does not impair dendritic targeting of *Arc* RNA that is microinjected directly into the cytoplasm (Gao et al. [@CR42]). Once in the cytoplasm, transport to dendrites appears to require a small 11 nucleotide response element within the *Arc* coding region that serves as a binding site for heterogeneous nuclear ribonucleoprotein (hnRNP) A2. The A2RE is found in several other dendritically targeted mRNAs, and there is indication that A2 can sequester the mRNAs encoding Arc and α-CaMKII and package them together into the same particle, suggesting a partial co-regulation of the two mRNAs (Gao et al. [@CR42]). The authors raise the possibility that *cis*-acting elements in the *Arc* 3′UTR mediate steady-state levels of mRNA expression in dendrites, while the A2RE mediates activity-dependent transport. Other components of *Arc* mRNPs are the translational repressor proteins fragile-X mental retardation protein (FMRP) and Purα that inhibit translation of the mRNA during transport (Zalfa et al. [@CR152]; Kanai et al. [@CR56]). Besides its role as a translational repressor, FMRP can act as an adaptor protein for the molecular motor complex kinesin (Davidovic et al. [@CR32]; Dictenberg et al. [@CR34]). This interaction increases during neuronal activity and can regulate transport of α-*CaMKII* mRNA, suggesting a mechanism whereby neuronal activity may enhance transport of mRNPs in general.

Kinesin as a motor complex for *Arc* mRNA is also indicated by the fact that *Arc* is co-purified with the kinesin heavy chain KIF5 (Kanai et al. [@CR56]). Moreover, constructs encoding the 3′UTR of *Arc* in cultured neurons undergo fast, directed movement with a maximum speed of 60 μm/min, indicating active motor-dependent transport (Dynes and Steward [@CR37]). This transport in unstimulated neurons is similar to that observed for other mRNPs or vesicles: particles can be stationary, oscillate, move bidirectionally, or move in a single direction over short periods, averaging a speed of 14--17 μm/min (Dynes and Steward [@CR37]). The translocation rate of *Arc* mRNA in vivo (300 μm in 1 h) is consistent with a fast, directed transport interspersed with pauses of variable duration. However, this calculation does not account for the possibility that transport of mRNPs may be altered by neuronal activity. Transport of α*-CamKII* mRNA becomes biased toward the anterograde direction when cells are depolarized (Rook et al. [@CR112]). Since this RNA is partially co-packaged with *Arc,* this phenomenon may also apply to *Arc* transport.

Within dendrites, *Arc* accumulates in regions where synapses have been recently activated (Steward et al. [@CR127]; Steward and Worley [@CR126]). This depends on local actin polymerization and signaling through NMDARs and Rho kinase (Huang et al. [@CR50]). The data suggest that *Arc* localization results from microtubule-dependent fast transport followed by F-actin-dependent docking, as it does for many localized RNAs in other cell types (Lopez de and Jansen [@CR73]). An interesting feature here is that Arc protein itself is required for stabilization of F-actin at active synapses, suggesting a positive feedback loop (Messaoudi et al. [@CR81]; Bramham [@CR14]). Since F-actin is necessary but not sufficient for *Arc* localization, additional local signals are required for this docking. ERK activation was identified as one of these signals, but the sequence of events in this process is not entirely elucidated (Huang et al. [@CR50]).

Translational control and local arc synthesis {#Sec4}
=============================================

A variety of post-transcriptional mechanisms exist for controlling the timing, location, and amount of protein synthesis in response to synaptic inputs, neuronal firing activity, or hormonal influences. One important feature of Arc regulation is translation-dependent RNA decay (Fig. [1](#Fig1){ref-type="fig"}). Work of Giorgi and colleagues suggests that *Arc* is a physiological target for a process known as nonsense-mediated RNA decay (NMD) (Giorgi et al. [@CR44]; Peebles and Finkbeiner [@CR101]). Conventionally, NMD serves as a quality control surveillance mechanism for the rapid elimination of aberrant mRNAs with stop codons situated upstream of a splice site (Wittmann et al. [@CR147]; Giorgi et al. [@CR44]; Ni et al. [@CR92]; Chang et al. [@CR25]). During pre-mRNA splicing in the nucleus, exon-junction complex (EJC) proteins consisting of an RNA-binding tetrameric core (eI4AIII, MLN51, Y14, and MAGOH) are deposited on the RNA and subsequently removed by the ribosome during the first round of translation, allowing bulk rounds of translation to proceed. In the advent of a premature stop codon, recruitment of a key NMD factor, UPF1, leads to degradation of the RNA after a single round of translation (Maquat [@CR77]). *Arc* becomes a natural target for NMD by virtue of the presence of two introns in the 3′UTR of the gene, resulting in EJC assemblage downstream of the stop codon (Giorgi et al. [@CR44]). In hippocampal neurons stimulated with BDNF, 59% of *Arc* granules in dendrites colocalize with the core NMD protein eI4AIII, strongly suggesting that *Arc* has not been translated prior to reaching the dendrite. Confirming the functional impact of NMD, knockdown of eI4AIII enhances *Arc* RNA and protein expression and selectively increases the amplitude of miniature excitatory postsynaptic currents (mEPSCs). While NMD severely limits Arc synthesis, more than one round of translation is distinctly possible. Some 41% of *Arc* RNA granules in dendrites do not colocalize with eIF4AIII, indicating that these transcripts survived the first round of translation. The estimated half-life of *Arc* mRNA in dissociated hippocampal neurons is 47 min (Rao et al. [@CR108]). As discussed later on, the rapid degradation of *Arc* by NMD is a highly distinctive feature that fits conceptually with the requirement for sustained translation of new *Arc* mRNA in LTP consolidation.

Translation initiation is the rate-limiting step in protein synthesis, and therefore subject to stringent regulation and modulation (Proud [@CR106]; Sonenberg and Hinnebusch [@CR121]). Formation of a translationally competent ribosome relies on the cooperation of numerous translation factors. A key component in this process is the translation factor eukaryotic initiation factor 4E (eIF4E), which binds to the 7-methylguanosine 5-triphosphate cap on the 5′-end of the mRNA and promotes recruitment of the 43S preinitiation complex. Phosphorylation of eIF4E on Ser^209^ correlates with enhanced rates of cap-dependent translation, whereas hypo-phosphorylation is associated with decreased translation (Richter and Sonenberg [@CR110]). eIF4E is phosphorylated by MAP kinase integrating kinase-1 (MNK1) in response to ERK activation. The mammalian target of rapamcyin complex 1 (mTORC1) also plays an important role by regulating the availability of the eIF4E for cap-binding. eIF4E is sequestered by eIF4E-binding proteins (eIF4E-BPs), but mTORC1-dependent phosphorylation of the binding protein induces release of sequestered eIF4E and facilitates initiation.

ERK and mTOR operate synergistically in regulation eIF4E in many situations requiring enhanced protein synthesis, including during LTP and mGluR-LTD in the hippocampal CA1 region (Banko et al. [@CR5], [@CR6]; Costa-Mattioli et al. [@CR30]). In the dentate gyrus, LTP consolidation requires a surprisingly sustained period of Arc synthesis starting within 10 min of HFS and lasting for 2--4 h (Messaoudi et al. [@CR81]). A recent study examined the regulation of translation factor activity during the critical period of Arc-dependent consolidation (Panja et al. [@CR97]). The authors found that HFS elicits rapid and sustained phosphorylation of the eIF4E which parallels the time-window of Arc synthesis. ERK-dependent signaling to MNK1 was necessary for eIF4E phosphorylation, enhanced initiation complex formation, and Arc protein expression. Synthesis of *Arc* mRNA persists for at least 30 min post-HFS and is also ERK dependent. Blockade of ERK signaling eliminates *Arc* mRNA, consistent with the sustained translation and rapid degradation of new *Arc* mRNA during LTP maintenance. Importantly, pharmacological inhibition of MNK1 abolishes Arc protein expression but not *Arc* mRNA. Taken together, this suggests a coordination role for ERK in the transcription, docking, and translation of *Arc* mRNA. Surprisingly, Panja et al. ([@CR97]) also find that LTP maintenance and Arc expression are not affected by inhibition of mTORC1 signaling with rapamycin. Consistent with this finding, mTOR activation was dispensable for enhanced initiation complex formation. Although mTOR signaling to p70S6 kinase and ribosomal protein S6 was activated during LTP, inhibition of this signaling by rapamycin did not impact LTP maintenance during 4 h of recording.

The exact function of eIF4E phosphorylation remains enigmatic. Increases in eIF4E activity increase translation of subsets of mRNAs rather than affecting global translation (Richter and Sonenberg [@CR110]). It has been speculated that decreased binding of eIF4E to the cap structure as a result of phosphorylation could serve to speed scanning of the preinitiation complex to the translation startsite or accelerate recruitment of new initiation complexes (Proud [@CR106]). Such a mechanism could be decisive for transcripts like *Arc* that are only weakly initiated due to the strong secondary structure of their 5′UTRs. The 5′UTR of *Arc* and that of several other dendritically localized mRNAs contains an internal ribosomal entry site (IRES) which is capable of mediating cap-independent translation in vitro. Such a mechanism could be important when cap-dependent mechanisms are saturated, as may occur during intensive bouts of protein synthesis.

Neuronal activity also modulates the elongation step of protein synthesis through regulation of eukaryotic elongation factor-2 (eEF2) (Scheetz et al. [@CR115]; Sutton et al. [@CR128]). eEF2 is a GTP-binding protein that mediates translocation of peptidyl-tRNAs from the A-site to the P-site on the ribosome. Phosphorylation of eEF2 on Thr^56^ inhibits eEF2-ribosome binding and arrests peptide chain elongation (Ryazanov et al. [@CR113]; Nairn and Palfrey, [@CR90]). Paradoxically, eEF2 is phosphorylated in protein synthesis-dependent forms of LTP and LTD; yet, synthesis of several plasticity-related proteins, including Arc, is maintained (Chotiner et al. [@CR27]; Kanhema et al. [@CR57]; Park et al. [@CR99]; Panja et al. [@CR97]). By making elongation the rate-limiting step for protein synthesis, it has been suggested that eEF2 phosphorylation may selectively favor the translation of weak initiators such as *Arc* (Walden and Thach [@CR139]; Scheetz et al. [@CR115]; Belelovsky et al. [@CR7]; Kanhema et al. [@CR57]). Recent work shows that rapid Arc synthesis underlying mGluR-dependent LTD is dependent on eEF2 phosphorylation (Park et al. [@CR99]).

In hippocampal neuronal cultures, NMDAR activation of the PKA pathway enhances Arc protein expression during pharmacological blockade of *Arc* transcription (Bloomer et al. [@CR11]), but the downstream mechanisms are currently unknown.

Arc protein function in long-term synaptic plasticity {#Sec100}
=====================================================

In vivo studies in dentate gyrus have shown that inhibition of Arc by intrahippocampal infusion of Arc antisense (AS) oligodeoxynucleotides impairs the maintenance but not the induction of LTP (Guzowski et al. [@CR301]; Messaoudi et al. [@CR81]). In *Arc* knockout mice, early phase LTP is enhanced while late phase LTP is blocked in both the dentate gyrus in vivo and in the CA1 region of acute hippocampal slices (Plath et al. [@CR104]). Recently, the dynamics of Arc function were explored by local infusion of Arc AS at various times after LTP induction (Messaoudi et al. [@CR81]). Infusion of Arc AS at 2 h (but not 4 h) post-HFS led to complete and permanent reversal of LTP and rapid knockdown of induced Arc mRNA and protein expression. Brief infusion of Arc AS at 15 min post-HFS reverses LTP only transiently, and the recovery phase is accompanied by enhanced Arc synthesis. The evidence suggests: (1) that LTP consolidation requires *sustainedArc* translation during a time-window that starts within minutes of LTP induction and lasts for 2--4 h, and (2) that Arc protein underlying LTP consolidation is rapidly degraded (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Arc protein function. **a** Schematic representation of Arc protein domains and binding motifs. The endophilin and dynamin binding sites mediate AMPAR endocytosis in synaptic depression. The PEST sequence, a region rich in the amino acids proline (P), glutamate (E), serine (S), or threonine (T), could target Arc for proteasomal degradation. **b** Arc is required for LTP consolidation through regulation of F-actin expansion. F-actin functions in PSD remodeling and spine enlargement, and is recently implicated in the sustained phosphorylation of translation initiation factor eIF4E during LTP. Synaptic depression in homeostatic plasticity and LTD is mediated by AMPAR endocytosis. **c** Arc functions. Arc plays critical roles in synaptic plasticity and memory storage. Functions in neurogenesis, drug addiction, and resilience to stress have been suggested but causal roles have not been defined

In addition to gene expression, formation of late phase LTP involves enduring structural changes, including expansion of the postsynaptic density and enlargement of postsynaptic dendritic spines (Matsuzaki et al. [@CR78]; Bourne and Harris [@CR13]). These structural changes depend on accumulation of F-actin as well as new protein synthesis (Fukazawa et al. [@CR40]; Bramham [@CR14]; Tanaka et al. [@CR129]). One of the major regulators of F-actin dynamics in spines is cofilin, which in its phosphorylated state promotes actin polymerization. In the study of Messaoudi et al. ([@CR81]), inhibition of LTP consolidation was associated with rapid dephosphorylation of hyperphosphorylated cofilin and corresponding loss of nascent F-actin at medial perforant path synapses. Importantly, the ability of Arc AS to reverse LTP was blocked by the F-actin stabilizing drug, jasplakinolide. Taken together, this strongly suggests that Arc promotes LTP consolidation through regulation of actin dynamics.

F-actin formation has long been implicated in the fine-localization of the translational machinery and the activity of certain F-actin associated translation factors (Smart et al. [@CR120]; Gross and Kinzy [@CR45]). This prompted investigation of whether regulation of actin dynamics by newly synthesized Arc contributes to the maintenance of eIF4E phosphorylation during LTP in the dentate gyrus in vivo (Tiron and Bramham [@CR132]). Remarkably, infusion of Arc AS during LTP maintenance blocked hyperphosphorylation of eIF4E. The same treatment had no effect on enhanced rpS6 phosphorylation, suggesting translation factor specificity. Furthermore, prior infusion of jasplakinolide rescued LTP and eIF4E phosphorylation. Thus, Arc synthesis is coupled to F-actin dynamics and regulation of eIF4E phosphorylation during LTP.

Several lines of evidence support a role for brain-derived neurotrophic factor (BDNF) as a trigger of protein synthesis-dependent LTP (Bramham and Messaoudi [@CR15]; Lynch et al. [@CR76]). HFS of excitatory input triggers release of BDNF leading to activation of postsynaptic TrkB receptors which can mobilize further BDNF secretion. Stimulus protocols generating late phase LTP are associated with a period of sustained BDNF release, and disruption of the BDNF-TrkB interaction blocks late phase LTP. Exogenous application of BDNF induces a lasting potentiation of excitatory synaptic transmission (BDNF-LTP) in several brain structures. BDNF-LTP in the dentate gyrus is transcription dependent, occluded by prior expression of late phase LTP, and associated with transport of *Arc* mRNA into granule cell dendrites (Messaoudi et al. [@CR80]; Ying et al. [@CR150]). Recently, inhibition of Arc synthesis with AS treatment was shown to abolish BDNF-LTP induction without affecting baseline transmission (Messaoudi et al. [@CR81]). Furthermore, the maintenance of BDNF-LTP and cofilin phosphorylation are rapidly inhibited by Arc AS application during a critical time window, as seen for HFS-LTP. Thus, exogenous BDNF activates *Arc* transcription and Arc synthesis-dependent LTP.

There is also strong evidence for Arc involvement in activity-dependent depression of excitatory synaptic transmission observed in mGluR-dependent LTD and homeostatic plasticity (Fig. [2](#Fig2){ref-type="fig"}). These effects are mediated through interaction of Arc with components of the endocytic machinery (dynamin and endophilin 2/3) leading to internalization of surface AMPAR-type glutamate receptors (Chowdhury et al. [@CR28]; Rial Verde et al. [@CR109]; Shepherd et al. [@CR117]; Park et al. [@CR99]; Waung et al. [@CR145]). Neurons expressing the Arc transgene have reduced evoked and spontaneous AMPAR-mediated EPSCs with no changes in NMDAR-mediated currents (Rial Verde et al. [@CR109]), indicating a mechanism specific to postsynaptic AMPARs. During homeostatic plasticity, steady-state increases in neuronal activity lead to a downscaling of surface AMPAR expression and global weakening of excitatory synaptic inputs without altering the relative strengths of the inputs (Turrigiano [@CR134]). In hippocampal neuronal cultures, decreases in neuronal firing activity during tetrodotoxin treatment enhance Arc expression while increases in activity in the presence of a GABA-A receptor blocker decrease Arc expression (Chowdhury et al. [@CR28]). The homeostatic scaling of AMPARs is abolished in*Arc* KO neurons, while Arc overexpression prevents the increase in AMPAR function associated with chronic activity blockade (Chowdhury et al. [@CR28]; Rial Verde et al. [@CR109]; Shepherd et al. [@CR117]; Waung et al. [@CR145]).

mGluR-LTD induced by low-frequency stimulation or application of DHPG requires rapid protein synthesis and endocytosis of AMPARs. Waung et al. ([@CR145]) showed the DHPG-LTD in CA1 pyramidal cells requires rapid translation of *Arc* in dendrites. Furthermore, acute inhibition of Arc synthesis blocked a persistent increase in AMPAR endocytosis rates. Similarly, in hippocampal slices from *Arc* KO mice, pharmacologically and synaptically evoked mGluR-dependent LTD are both suppressed and treatment with DHPG fails to decrease surface expression of GluR1 (Park et al. [@CR99]). Park et al. ([@CR99]) also provide compelling evidence that enhanced translation of *Arc* during mGluR-LTD relies on eEF2 function. Arc synthesis and mGluR-LTD are inhibited in acute hippocampal slices from eEF2 kinase KO mice, but the wildtype phenotype can be reinstated in slices exposed to low-dose cycloheximide, a treatment known to enhance eEF2 phosphorylation. As mentioned previously, the RNA-binding protein FMRP is proposed to physiologically repress translation of target mRNAs in dendrites, including *Arc* (Zalfa et al. [@CR152]). mGluR activation results in dephosphorylation of FMRP and relieves the translational inhibition (Antar et al. [@CR300]; Narayanan et al. [@CR302]). In *fmr1* KO mice, aberrantly enhanced translation is associated with elongated spines and behavioral deficits mirroring the mental retardation syndrome. Park et al. ([@CR99]) show that rapid synthesis of Arc is impaired in *fmr1* KO mice. FMRP, however, is not required for eEF2 phosphorylation, suggesting parallel pathways from group I mGluRs to eEF2 kinase and FMRP in the regulation of Arc synthesis in mGluR-LTD.

Studies exploring the role of Arc in NMDAR-dependent LTD have produced mixed results. Favoring a role, LFS-induced LTD of the Schaffer collateral-CA1 synapse is reduced in acute hippocampal slices from *Arc* KO mice (Plath et al. [@CR104]) and overexpression of *Arc* transgene occludes NMDAR-dependent LTD in organotypic hippocampal slices (Rial Verde et al. [@CR109]). On the other hand, stimuli that typically induce LTD (1 Hz LFS) do not induce *Arc* transcription or translation (Steward and Worley [@CR126]). In the study of Waung et al. ([@CR145]), LTD induced by application of NMDA only transiently increased AMPAR endocytosis rates and did not induce Arc expression, or require Arc protein. However, in agreement with previous work (Rial Verde et al. [@CR109]), overexpression of GFP-tagged Arc inhibited NMDA-induced endocytosis of AMPARs. It has therefore been suggested that extreme changes in Arc levels (knockout or overexpression) impact both NMDAR and mGluR-LTD, whereas mGluR-LTD is selectively sensitive to more subtle activity-evoked changes in Arc synthesis (Waung et al. [@CR145]).

Arc protein localization, post-translational modification, and turnover {#Sec6}
=======================================================================

The known domain structure of the 396 amino acid Arc protein is shown in Fig. [2](#Fig2){ref-type="fig"}a. Biochemically, Arc co-sediments with crude F-actin but not with more highly purified actin suggesting an indirect association of Arc with the cytoskeleton via an actin-binding protein (Lyford et al. [@CR75]). Cofilin activity is regulated by Arc synthesis, but there is no evidence of a direct interaction between cofilin and Arc. Pulldown and co-immunoprecipitation experiments suggest that Arc complexes with PSD-95 and CaMKII in the PSD fraction (Husi et al. [@CR51]; Donai et al. [@CR36]). A recent extensive analysis employing yeast 2-hybrid, co-immunoprecipitation, and binding assays identified Arc binding domains for endophilin 3 and dynamin 2. Arc also has a coiled-coil domain and a spectrin homology domain in the C-terminal half which may mediate interactions with other spectrin repeat containing proteins (Link et al. [@CR72]; Lyford et al. [@CR75]), though no such interactions have been described.

Morphologically, immunocytochemical detection of endogenous Arc at the light microscopic levels shows colocalization of Arc with the cytoskeleton, synaptic puncta, and the nucleus (Link et al. [@CR72]; Lyford et al. [@CR75]; Steward et al. [@CR127]; Bloomer et al. [@CR10]; Chowdhury et al. [@CR28]). At the ultrastructural level, immuno-electronmicroscopy shows Arc throughout dendritic spines, with concentrated labeling in the PSD and detectable labeling in vesicular-like structures (Moga et al. [@CR84]; Rodriguez et al. [@CR111]; Chowdhury et al. [@CR28]). Following LTP induction, Arc protein is found across the dendritic arbor of principal neurons of the hippocampus, and electron microscopy reveals selective accumulation of Arc protein in spines within the termination zone of the activated fibers (Rodriguez et al. [@CR111]). The exact sites of dendritic Arc synthesis are unknown, but evidence for polyribosome and RNA trafficking to spines (Ostroff et al. [@CR93]; Havik et al. [@CR48]; Yoshimura et al. [@CR151]), docking of *Arc* mRNA to the cytoskeleton (Huang et al. [@CR50]), and Arc synthesis in isolated synaptoneurosomes (Yin et al. [@CR149]) suggests that synthesis occurs at least partly in spines.

Arc accumulates in the nucleus, but its function there is unknown. As Arc lacks a consensus nuclear localization signal (NLS), its nuclear transport may require domain-specific protein interactions or post-translational modifications. A protein known as Amida has been implicated in Arc nuclear import (Irie et al. [@CR54]). Evidence from COS7 cells suggests that Arc is ferried to the nucleus upon binding to the region between two canonical NLSs in Amida, but information from neurons is lacking. Inside the nucleus, Arc forms multiple nuclear puncta and associates with promyelocytic leukemia nuclear bodies (PML-NBs) (Bloomer et al. [@CR10]). PML-NBs are discrete nuclear foci present in most mammalian nuclei and have been implicated as sites of protein storage and release, post-translational modification, transcriptional activation and repression, and heterochromatin formation (Zhong et al. [@CR156]; Borden [@CR12]). According to Bloomer et al. ([@CR10]), Arc interacts with PML-NBs by binding to a nuclear spectrin isoform (βSpIV∑5). Arc binding is mediated by a portion of the N-terminus (aa 26-154) containing the coiled-coil domain and does not involve the C-terminal spectrin repeat domain.

In LTP experiments, Arc AS induces a 50% knockdown of Arc protein expression within 1 h of infusion, consistent with rapid turnover of Arc protein underlying LTP consolidation (Messaoudi et al. [@CR81]). In cultured hippocampal neurons, Arc degradation is blocked by pharmacological inhibition of the ubiquitin proteasomal system (UPS). Arc also has a PEST sequence \[rich in proline (P), glutamate (E), serine (S), and threonine (T)\] in its C-terminus (residues 351--392) which may target it for proteasomal degradation (Rao et al. [@CR108]). In the presence of proteasomal inhibitors, BDNF-induced increases in Arc protein levels reach baseline levels in 3 h but are stably elevated in controls. These results are at odds with a study employing the photoconvertible fluorescent protein monomeric Eos, in which photoconverted Arc-Eos exhibited stable levels of fluorescence for at least 3 h (Bloomer et al. [@CR11]). Further time-lapse imaging studies examining the rates of Arc degradation in neuronal subcompartments are needed.

The post-translational addition of a protein called small ubiquitin-like modifier (SUMO) has emerged as major mechanism for regulating the intracellular localization, protein interactions, turnover, and activity of target proteins (Meulmeester and Melchior [@CR82]). Post-translational modification by SUMO, a family of proteins of approximately 10 kD, is carried out by a cascade of enzymes similar to that involved in ubiquitination. Recent work has identified two consensus SUMOylation sites in Arc that direct its subcellular localization to dendrites and the cytoskeleton (Nair et al. [@CR89], unpublished observations). In vitro SUMOylation assays performed with immunoprecipitated Arc demonstrate direct Arc SUMOylation, and single amino acid substitutions (lysine to alanine) of the consensus SUMOylation sites disrupt the subcellular localization pattern of Arc in dendrites. Interestingly, BDNF treatment of hippocampal neurons induces colocalization of endogenous Arc with SUMO1 and PSD-95. Following LTP induction in dentate gyrus of anesthetized rats, SUMOylated Arc massively accumulates in the cytoskeletal fraction relative to cytosolic, membrane, or nuclear fractions. These data raise the intriguing possibility that SUMOylation of Arc directs its interaction with the cytoskeleton during LTP consolidation.

Arc and memory consolidation {#Sec7}
============================

Guzowski and colleagues originally showed that intrahippocampal infusion of Arc AS impairs LTP consolidation and long-term spatial memory without affecting acquisition and short-term memory performance (Guzowski et al. [@CR301]). In a recent in-depth behavioral analysis of homozygous *Arc* knockout mice, Plath et al. ([@CR104]) establish a selective requirement for Arc in long-term memory for a variety of hippocampal-dependent and hippocampal-independent tasks, including spatial learning in the Morris water maze, auditory and context-dependent fear conditioning, conditioned taste aversion, and object recognition. Using Arc AS infusion, McIntyre et al. ([@CR79]) show that Arc synthesis in the dorsal hippocampus is also necessary for inhibitory avoidance memory. Moreover, hippocampal Arc synthesis and memory performance were both modulated by activation of β-adrenoreceptors in the basolateral complex of the amygdala, indicating an important role for extrinsic inputs in modulating Arc function in the hippocampus. In the lateral amygdala, Pavlonian fear conditioning results in enhanced expression of Arc that is ERK dependent and selectively required in the formation of long-term memory (Ploski et al. [@CR105]). Together, these studies support a role for Arc in diverse forms of long-term memory in the rodent brain.

Studies over the last decade have exploited the rapid expression of immediate early genes such as *Arc*, *c-fos*, *zif268*, and *homer1a* to map neuronal populations and circuits engaged in distinct forms of learning (Guzowski et al. [@CR47]; Montag et al. [@CR86]; Vazdarjanova et al. [@CR137]; Kelly and Deadwyler [@CR60]; Montag-Sallaz and Montag [@CR87]; Vazdarjanova and Guzowski [@CR136]; Gusev et al. [@CR46]; Kubik et al. [@CR64]; Soule et al. [@CR122]). Work of Vazdarjanova and Guzowski ([@CR136]) further established a tight link between*Arc* transcription and neural activity specifically associated with information processing in hippocampal subfields. Taking advantage of *Arc* mRNA processing (splicing) in the nucleus and rapid transit to cytoplasm, these authors used fluorescence in situ hybridization of nuclear and cytoplasmic *Arc* to map the effects of multiple behavioral experience in the same rat. They were able to show that repeated behavioral exploration of an environment elicited *Arc* transcription in the same discrete population of hippocampal pyramidal cells, while exposure to two completely different environments activates a partly non-overlapping neuronal population. These observations are quantitatively and qualitatively similar to those obtained in single-unit recording studies of place cell firing in the hippocampus (Guzowski et al. [@CR47]). In a recent study, Miyashita and colleagues studied the role of the medial septal input to the hippocampus on *Arc* mRNA expression in rats walking on a closed track. The medial septum was inactivated by intraseptal infusion of tetracaine anesthetic, a treatment previously shown to attenuate the hippocampal theta rhythm without affecting the location-specific firing of CA3 and CA1 neurons (Fletcher et al. [@CR39]; Miyashita et al. [@CR83]). Behaviorally induced *Arc* expression was blocked by this treatment, suggesting that *Arc* transcription in CA3-CA1 ensembles depends on input from medial septum and possibly the presence of the hippocampal theta rhythm.

Memory loss in Alzheimer's disease (AD) is associated with loss of connectivity in hippocampal and cortical networks. In transgenic mice expressing human amyloid precursor protein (hAPP) and hAPP-derived amyloid-β (Aβ), Arc expression is reduced primarily in granule cells of the dentate gyrus (Palop et al. [@CR95]). In cultured cortical neurons, BDNF-induced Arc expression is suppressed even at sublethal levels of Aβ (Wang et al. [@CR143]). Other investigators reported that exposure of dissociated hippocampal neurons to neurologically active Aβ oligomers termed Aβ-derived diffusible ligands (ADDLs) produces upregulation of Arc and lengthening of dendritic spines followed by reductions in synapse density (Wang et al. [@CR142]; Lacor et al. [@CR66]; Viola et al. [@CR138]). Together, this work suggests that dysregulation of Arc expression could contribute to cognitive impairment and memory loss in AD.

Aging is associated with deterioration of neuronal function in the hippocampus rather than frank cell loss and degeneration. Studies in rats, monkeys, and humans point to the dentate gyrus as the region most susceptible to the functional decline with advanced age. Using fluorescence in situ hybridization, Small et al. ([@CR119]) showed that the proportion of granule cells expressing *Arc* RNA following spatial exploration decreases with advanced age, whereas pyramidal neurons of CA3 and CA1 region show no age-related change in *Arc* expression. As proposed by Burke and Barnes ([@CR20]), the decline in behaviorally evoked*Arc* expression in dentate granule cells could reflect age-related impairments in place cell activity and place field formation or uncoupling of *Arc* transcription from granule cell activity.

Arc, antidepressants, and drugs of abuse {#Sec8}
========================================

The behavioral effects of antidepressants in animal models of depression and the therapeutic effects in humans typically take several weeks to develop. Upregulation of BDNF expression and enhanced TrkB receptor signaling in the dentate gyrus, hippocampus, and cortex is implicated in the mechanism of action of antidepressant drugs such as the selective serotonin reuptake inhibitors (SSRIs). While BDNF has diverse functions, it is commonly thought that TrkB signaling during antidepressant treatment promotes or restores plasticity in affected circuits through regulation of gene expression (Castren et al. [@CR24]; Dagestad et al. [@CR31]). As discussed, *Arc* has been identified as a critical effector gene for BDNF in the context of BDNF-induced LTP in the dentate gyrus. Several studies have reported upregulation of Arc in forebrain structures in which TrkB signaling is enhanced by antidepressants (Pei et al. [@CR102]; Alme et al. [@CR2]; Larsen et al. [@CR67]; Molteni et al. [@CR85]). A recent microarray study further identified a panel of nine genes that are strongly upregulated with *Arc* during BDNF-LTP and HFS-LTP in the dentate gyrus and five genes selected for validation by RT-PCR and in situ hybridization were confirmed upregulated in dentate granule cells (Wibrand et al. [@CR146]). The gene set includes several genes with known synaptic roles, such as neuronal activity-regulated pentraxin (Narp) and neuritin. Interestingly, the BDNF-regulated genes exhibited a region-specific pattern of upregulation in the prefrontal cortex, hippocampus, and dentate gyrus, after chronic (but not acute) treatment with the SSRI fluoxetine (Alme et al. [@CR2]).

Downregulation of BDNF following traumatic life events or stress is thought to contribute to depression, but animal studies clearly indicate that removal of BDNF in rat forebrain does not precipitate depressive-like behavior (Krishnan and Nestler [@CR63]). Nevertheless, in a study employing predator scent as stressor, rats whose behavior is minimally disrupted by exposure to the predator scent had increased levels of *Arc* mRNA expression in hippocampus, whereas the rats whose behavior was severely disrupted demonstrated no such upregulation (Kozlovsky et al. [@CR62]). These data were interpreted in support of a possible role for Arc expression in resilience to adverse life events. At the moment, however, there is no evidence causally linking Arc to any aspect of depression or the action of antidepressants, nor is there solid evidence that depression or recovery from depression involves alterations in the capacity for long-term modification of existing synapses (LTP and LTD) as opposed to synaptogenesis or neurogenesis.

Drug addiction involves adaptive changes in the nervous system that are maintained after drug withdrawal (Hyman et al. [@CR52]). It has been suggested that mechanisms subserving memory storage are hijacked in the context of drug addiction and relapse. Opiate withdrawal, for example, leads to the emergence of an aversive state that can be conditioned to a specific environment. Reactivation of these withdrawal memories has been suggested to trigger relapse of drug-seeking behavior in abstinent opiate addicts. A pair of recent studies demonstrated enhanced Arc expression, most prominently in the basolateral nucleus of the amygdala, during the acquisition of conditioned place aversion and following re-exposure of rats to the withdrawal-paired environment (Lucas et al. [@CR74]; Li et al. [@CR70]). In the study of Li et al. ([@CR70]), Arc expression was seen following place aversion elicited by conditioned naloxone-precipitated drug withdrawal following exposure to a single dose of morphine. Another important issue is whether long-term changes can develop after the first *voluntary* drug exposure. Fumagalli et al. ([@CR41]) found that a single session of intravenous cocaine self-administration increased the levels of*Arc* (but not*zif268*) in medial prefrontal cortex relative to yoked controls receiving cocaine or vehicle infusion (Fumagalli et al. [@CR41]). The role of Arc in alcoholism has also been studied in rat models. The anxiolytic effects of acute ethanol exposure are associated with enhanced BDNF and TrkB expression, ERK phosphorylation, Arc expression and increased dendritic spine density in the central and medial amygdala (but not in the basolateral amygdala) (Pandey et al. [@CR96]). Conversely, these effects were all decreased during ethanol withdrawal associated with increased anxiety-like behavior. Infusion of BDNF into the central amygdala normalized Arc expression and protected against withdrawal-related anxiety in ethanol-treated rats. Intra-amygdala infusion of Arc AS was also reported to increase anxiety-like behavior in rats that were not given ethanol.

The psychostimulant drugs methylphenidate and [d]{.smallcaps}-amphetamine are widely prescribed in the treatment of attention-deficit/hyperactivity disorder (ADHD). Two recent studies in rats report age-specific and brain region-specific effects of these drugs on expression of BDNF and Arc. In adult rats administration of psychostimulants increased*Arc* mRNA levels in many forebrain structures, while in juveniles*Arc* mRNA expression was decreased in the hippocampus and parietal cortex (Chase et al. [@CR26]; Banerjee et al. [@CR4]). The authors suggest that decreased*Arc* expression in juveniles may be related to the reported long-term harmful effects of psychostimulants in animal models, with possible ramifications for the treatment of children diagnosed with ADHD.

Arc and neurogenesis {#Sec101}
====================

Neurogenesis is a vital form of neural plasticity occurring solely in the subventricular zone (SVZ) of the olfactory bulb and the subgranular zone (SGZ) of the hippocampal dentate gyrus. Ongoing throughout life in the adult mammalian brain, neurogenesis encompasses the proliferation of neural stem and progenitor cells as well as their differentiation, migration and eventual incorporation into the pre-existing circuitry (Doetsch and Hen [@CR35]; Zhao et al. [@CR155]) Alongside activity-dependent synaptic plasticity (Morris [@CR88]; Pastalkova et al. [@CR100]), neurogenesis of dentate granule cells (DGCs) is recognized as a major contributor to hippocampal-dependent memory function (Shors et al. [@CR118]; Bruel-Jungerman et al. [@CR18]; Leuner et al. [@CR69]; Zhang et al. [@CR153]; Farioli-Vecchioli et al. [@CR38]; Imayoshi et al. [@CR53]). Despite a constant supply of neuronal precursors provided by the progenitor cells, only a small fraction of these survive to develop, mature and functionally integrate into the pre-existing neuronal networks (Cameron et al. [@CR22]; Cameron and McKay [@CR21]; Dayer et al. [@CR33]; Zhao et al. [@CR155]). A major challenge is thus to understand the stringent selection process that governs the selective survival and integration of adult-born dentate granule cells.

Given the crucial role for Arc in LTP consolidation, Kuipers et al. ([@CR65]) considered that the ability to induce Arc in newborn granule cells could be used to map their functional maturation. LTP was induced in the perforant path and Arc expression was examined in cells birthmarked by bromodeoxyuridine (BrdU) injection during the first 4 weeks of maturation. Contrary to the expectation, LTP induction within the perforant path does not detectably increase Arc expression in newborn DGCs, suggesting that young neurons are refractory to synaptically evoked Arc expression. Furthermore, Arc is expressed from a very early post-mitotic age---as early as 1 day after birth, with its expression strongly associated with the long-term survival and neuronal differentiation of newly generated cells. Since such early expression (i.e. 1 or 7 days post-mitosis) precedes the formation of glutamatergic synapses on new neurons (Overstreet-Wadiche and Westbrook [@CR94]; Zhao et al. [@CR154]; Toni et al. [@CR133]), these findings suggest a novel function for Arc in neurogenesis, distinct from its role in LTP, LTD and homeostatic synaptic plasticity.

Such early and spontaneous expression of Arc has not been observed for other IEGs, including c-fos, zif268, or homer1a (Jessberger and Kempermann [@CR55]; Bruel-Jungerman et al. [@CR19]; Kee et al. [@CR59]). The latter IEGs can be induced experimentally on a developmental time course that corresponds to the time of synapse formation at approximately 2 weeks (Schmidt-Hieber et al. [@CR116]; Ge et al. [@CR43]). The spontaneous expression in early newborn cells (less than 4 weeks of age), appears to be a unique property of Arc among the IEGs. The refractory nature of new neurons to HFS-evoked Arc induction is also intriguing and all the more surprising since 1--3-week-old neurons have lower thresholds for LTP induction relative to pre-existing DGCs (Bruel-Jungerman et al. [@CR19]; Kee et al. [@CR59]; Jessberger and Kempermann [@CR55]). The latter does not exclude the possibility that newborn neurons, with their own specific synaptic properties, display a form of LTP that is independent of Arc expression. Enhanced behavioral induction of Arc has been reported, however, in 5-month-old DGCs relative to the older, pre-existing neurons (Ramirez-Amaya et al. [@CR107]) as well as in 10-week-old DGCs (Kee et al. [@CR59]), suggesting that neurons undergo an early refractory period to evoked Arc expression which gives way to a state of heightened sensitivity as the neurons mature. Systematic comparisons of behaviorally-evoked and HFS-evoked expression of Arc and other IEGs across the full time-frame of DGC maturation are needed to test this hypothesis.

In the study of Kuipers and colleagues, a progressive increase in double BrdU/Arc positive cells was paralleled by a gradual time-dependent decline of Arc-negative new DGCs, raising the possibility that early Arc expression defines a subpopulation of newborn DGCs with the highest probability of survival and incorporation into the pre-existing hippocampal circuit. The mechanisms connecting Arc expression to neurogenesis will thus be important to explore. Currently two candidate mechanisms stand out, depending on the age of the neurons. In undifferentiated cells, prior to synapse formation, Arc could act directly in the nucleus to promote proliferation, differentiation, and survival. As mentioned, Arc accumulates in the nucleus of hippocampal neurons where it localizes to PML bodies (Bloomer et al. [@CR10]; Nair et al. [@CR89]), dynamic and heterogeneous protein complexes, implicated in transcription, heterochromatin formation, and post-translational modifications (Wang et al. [@CR303]; Zhong et al. [@CR156]; Borden [@CR12]) as well as cellular functions such as proliferation, apoptosis and senescence (Zhong et al. [@CR156]; Bernardi and Pandolfi [@CR8]; Sanchez-Pulido et al. [@CR114]). In older DGCs forming excitatory synapses, NMDAR activation and LTP induction facilitates long-term survival (Bruel-Jungerman et al. [@CR19]; Tashiro et al. [@CR130]). At this later stage, Arc might promote survival by enabling stable LTP.

Conclusions and future directions {#Sec10}
=================================

*Arc* transcription, RNA localization to activated synapses, and translation are all tightly coupled, with ERK playing a coordinating role in each of these events. Once translated, *Arc* RNA and protein are rapidly degraded. This has the makings of a specialized system for mediating adaptive changes in synaptic connectivity and behavior, in which the time, place, and amount of protein synthesis is critical.

Arc was originally identified as a cytoskeleton-associated protein. Bearing out this connection, recent studies link transient increases in Arc expression to stable expansion of the F-actin network in dendritic spines, which is believed to underlie morphological enlargement of the synapse and stable LTP. BDNF, a protein long implicated in synaptic plasticity and memory storage, activates Arc-dependent consolidation and is necessary for actin-dependent spine enlargement. Current evidence further suggests a possible reciprocal interaction between F-actin formation, Arc, and translation during LTP consolidation (Fig. [3](#Fig3){ref-type="fig"}). The sequence of events in a working hypothesis are as follows: (1) immediate, protein synthesis-independent formation of F-actin in spines, (2) mRNA docking to spine F-actin, (3) Arc synthesis-dependent cofilin phosphorylation and F-actin stabilization, and (4) F-actin dependent facilitation of translation factor eIF4E phosphorylation. Such a positive feedback mechanism could serve to sustain Arc synthesis and cap-dependent translation in activated spines during LTP consolidation in the dentate gyrus (Fig. [3](#Fig3){ref-type="fig"}). However, there are numerous outstanding issues, including the mechanism by which Arc synthesis promotes cofilin phosphorylation.Fig. 3Sequence of events in Arc-dependent LTP consolidation. This is a *working hypothesis* based mainly on studies of LTP in the medial perforant path input to granule cells of the rat dentate gyrus. Following LTP induction*Arc* mRNA is transported to dendrites where it localizes to the actin cytoskeleton within spines of activated synapses. Synaptically evoked ERK signaling coordinates*Arc* transcription, RNA docking, and translation. Arc synthesis within the spine is necessary for phosphorylation of cofilin and stable expansion of the F-actin network. In turn, regulation of actin dynamics by Arc is necessary for the maintenance of translation initiation factor eIF4E phosphorylation during LTP consolidation. Finally, phosphorylation of eIF4E, formation of the translation initiation complex, and Arc synthesis all require ERK signaling. Taken together, this has the makings of a positive feedback circuit which serves to sustain the local synthesis of Arc during the critical period of LTP consolidation. While not depicted here, it should be noted that BDNF is capable of activating Arc-dependent LTP consolidation. *BDNF* brain-derived neurotrophic factor; *eIF4E* eukaryotic initiation factor 4E; *ERK* extracellular signal-regulated kinase

Arc protein binds to components of the endocytic machinery, resulting in enhanced rates of AMPAR endocytosis and depression of excitatory synaptic transmission. This mechanism is activated during homeostatic plasticity and mechanistically distinct forms of LTD activated by group 1 mGluR and NMDARs. One of the most exciting unresolved issues in the field is how Arc switches between regulation of the cytoskeleton and LTP, to regulation of endocytosis and LTD (Fig. [2](#Fig2){ref-type="fig"}). One factor appears to be the amount and kinetics of Arc protein expression. Thus, increases in Arc synthesis resulting from inhibition of natural nonsense-mediated RNA decay increases mEPSC amplitude, while expression of *Arc* transgene has the opposite effect. Studies employing Arc AS oligos and RNAi suggest that LTP consolidation and mGluR-dependent LTD are sensitive to acute modulation of activity-dependent protein synthesis, whereas more extreme changes in Arc levels obtained with transgenic overexpression or knockouts affect additional mechanisms such as NMDAR-dependent LTD. Post-translational modification of Arc or of one of its binding-partners represents another potential means for dictating the functional mode of Arc as synapses. Recent work showing a selective enrichment of SUMOylated Arc in the cytoskeletal fraction is intriguing in this regard (Nair et al. [@CR89]; unpublished observations). By targeting Arc to the cytoskeleton, SUMOylation might favor Arc function in LTP consolidation. Whatever the mechanisms, current indications are that differential signaling through NMDAR, TrkB, and mGluR set the context for Arc function in LTP versus LTD.

Evidence for Arc synthesis in dendrites is compelling yet mostly circumstantial. Where does Arc travel from sites of synthesis in the dendrites and cell bodies? Does dendritically synthesized Arc selectively target spines undergoing LTP or LTD in the same neuron? What is the time course for these events? Novel approaches using time-lapse imaging are needed to address these fundamental issues. Ultimately, we need to know how this works in behaving animals. How are the various functions of Arc utilized to mediate adaptive and maladaptive changes of synaptic connectivity and behavior?*Arc* transcription has been correlated with learning experience and specific neuronal firing patterns, yet the synaptic regulation and function of Arc during learning remains unchartered ground. Once the molecular mechanisms that toggle Arc function are elucidated, it may be possible to devise reporter systems that visualize discrete sets of synapses undergoing potentiation and depression in living rodents.
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